AstraZeneca Pharma India said that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import and distribute Olaparib film-coated tablets 100 mg & 150 mg (Lynparza ...
ShareChat reports a 67% decline in adjusted EBITDA losses to Rs 793 crore in FY24, with revenue growth of 33%. The company is on track for cash breakeven by March 2025 and exploring an IPO in the next ...